Related Articles
Phase I study of weekly palliative chemotherapy with low-dose third-line paclitaxel for biliary tract cancer
Successful treatment of unresectable gallbladder cancer with low-dose paclitaxel as palliative chemotherapy after failure of gemcitabine and oral S-1: A case report
A phase I study of neoadjuvant chemotherapy with gemcitabine plus oral S-1 for resectable pancreatic cancer
Phase I study of docetaxel plus S-1 combination chemotherapy for recurrent non-small cell lung cancer
Comparing the cost-effectiveness of FOLFIRINOX, nab-paclitaxel plus gemcitabine, gemcitabine and S-1 for the treatment of metastatic pancreatic cancer